This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Mycophenolate vs Azathioprin in Autoimmune Hepatitis

This study has been completed.
Information provided by:
Rigshospitalet, Denmark Identifier:
First received: May 28, 2008
Last updated: May 29, 2008
Last verified: May 2008
A study with 20 de novo patients with autoimmune hepatitis, 10 receiving azathioprin and 10 receiving mycophenolat mofetil.

Condition Intervention Phase
Autoimmune Hepatitis Drug: Treatment with mycophenolat mofetil Drug: Treatment with azathioprin Phase 4

Study Type: Interventional
Study Design: Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Rigshospitalet, Denmark:

Arms Assigned Interventions
Active Comparator: I
Drug: Treatment with mycophenolat mofetil
Active Comparator: II Drug: Treatment with azathioprin


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • De novo autoimmune hepatitis
  • Consent

Exclusion Criteria:

  • age below 18
  • pregnancy
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00687180

Rigshospitalet, Dept. of Hepatology A-2121
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Rigshospitalet, Denmark
  More Information

Responsible Party: Bent Hansen, Chief of Dept. of Hepatology A-2121, Rigshospitalet, Denmark Identifier: NCT00687180     History of Changes
Other Study ID Numbers: MMF vs Imurel
Study First Received: May 28, 2008
Last Updated: May 29, 2008

Keywords provided by Rigshospitalet, Denmark:
Prednisolone dosage

Additional relevant MeSH terms:
Hepatitis, Autoimmune
Liver Diseases
Digestive System Diseases
Hepatitis, Chronic
Autoimmune Diseases
Immune System Diseases processed this record on September 21, 2017